Prof. Dr. HAKKI OGÜN SERCAN

Yayın Ağı

Makaleler 30

1. RESVERATROL STABILIZES CYTOSOLIC ß- CATENIN THROUGH THE ACTIVATION OF THE THERMOGENIC CASCADE

Sercan H. O.

JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES , sa.9, ss.604-611, 2025 (ESCI)

2. Study of the effect of sFRP1 protein on molecules involved in the regulation of DNA methylation in CML cell line

Demirkiran N., AYDIN B., Pehlivan M., YÜCE Z., SERCAN H. O.

Medical Oncology , cilt.41, sa.5, 2024 (SCI-Expanded)

3. Dvl proteins regulate SMAD1, AHR, mTOR, BRD7 protein expression while differentially regulating canonical and non-canonical Wnt signaling pathways in CML cell lines

Çalışkan C., Yüce Z., Sercan H. O.

GENE , cilt.20, sa.854, ss.1-10, 2023 (SCI-Expanded)

4. sFRP1 Expression Regulates Wnt Signaling in Chronic Myeloid Leukemia K562 Cells

Pehlivan M., Caliskan C., Yuce Z., Sercan H. O.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY , cilt.22, sa.7, ss.1354-1362, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

5. KML VE KML LÖSEMİK KÖK HÜCRESİ ARASINDA MİKRORNA EKSPRESYON DEĞİŞİMLERİNİN DEĞERLENDİRİLMESİ

Pehlivan M., Soyöz M., Karahan İ., Çerçi Gürbüz B., Kılıçaslan Ayna T., Ateş H., et al.

SDÜ Tıp Fakültesi Dergisi , cilt.27, sa.3, ss.315-321, 2021 (Hakemli Dergi)

6. Comparison of Wnt and Frizzled related gene expressions of Ph (+) CML cell lines with megakaryoblast and basophil cell types

PEHLİVAN M., SERCAN H. O.

CUKUROVA MEDICAL JOURNAL , cilt.46, sa.1, ss.318-324, 2021 (ESCI)

7. Investigation of R882H Mutation in the Gene Coding DNA Methyl Transferase 3A (DNMT3A) in Chronic Myeloid Leukemia (CML) Patients

Şirin N., Aydın B., PEHLİVAN M., SERCAN H. O.

Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi , cilt.34, ss.271-278, 2020 (Hakemli Dergi)

8. sFRP1 Expression Induces miRNAs That Modulate Wnt Signaling in Chronic Myeloid Leukemia Cells

Pehlivan M., Soyoz M., Cerci B., Coven H. I. K., Yuce Z., Sercan H. O.

MOLECULAR BIOLOGY , cilt.54, sa.4, ss.563-569, 2020 (SCI-Expanded)

9. Secreted Wnt antagonists in leukemia: A road yet to be paved

Pehlivan M., Caliskan C., Yüce Z., Sercan H. O.

LEUKEMIA RESEARCH , cilt.69, ss.24-30, 2018 (SCI-Expanded)

10. Dishevelled proteins and CYLD reciprocally regulate each other in CML cell lines

Caliskan C., Pehlivan M., Yüce Z., Sercan O.

MOLECULAR BIOLOGY REPORTS , cilt.44, sa.5, ss.391-397, 2017 (SCI-Expanded)

11. Forced expression of Wnt antagonists sFRP1 and WIF1 sensitizes chronic myeloid leukemia cells to tyrosine kinase inhibitors

Pehlivan M., Caliskan C., Yüce Z., Sercan H. O.

TUMOR BIOLOGY , cilt.39, sa.5, 2017 (SCI-Expanded)

12. Systematic Mapping of WNT-FZD Protein Interactions Reveals Functional Selectivity by Distinct WNT-FZD Pairs

Dijksterhuis J. P., Baljinnyam B., Stanger K., Sercan H. O., Ji Y., Andres O., et al.

JOURNAL OF BIOLOGICAL CHEMISTRY , cilt.290, sa.11, ss.6789-6798, 2015 (SCI-Expanded)

13. Cancer stem cell differentiation: TGF beta 1 and versican may trigger molecules for the organization of tumor spheroids

Oktem G., Sercan O., Guven U., Uslu R., UYSAL A., Goksel G., et al.

ONCOLOGY REPORTS , cilt.32, sa.2, ss.641-649, 2014 (SCI-Expanded)

14. Expression profiling of stem cell signaling alters with spheroid formation in CD133(high)/CD44(high) prostate cancer stem cells

ÖKTEM G., Bilir A., Uslu R., Inan S. V., Demiray S. B., ATMACA H., et al.

ONCOLOGY LETTERS , cilt.7, sa.6, ss.2103-2109, 2014 (SCI-Expanded)

15. An In-House Method for Molecular Monitoring of BCR-ABL

Sercan H. O., Ozturk I., Caliskan C., Pehlivan M., Sercan Z.

TURKISH JOURNAL OF HEMATOLOGY , cilt.29, sa.4, ss.348-353, 2012 (SCI-Expanded)

16. Expression profile of WNT, FZD and sFRP genes in human hematopoietic cells.

Sercan Z., Pehlivan M., Sercan H. O.

Leukemia research , cilt.34, sa.7, ss.946-9, 2010 (SCI-Expanded)

17. Beta-catenin mutations are not observed in chronic myeloid leukemia.

Sercan Z., Pehlivan M., Gokturk D., Sercan H. O.

Tumori , cilt.95, sa.6, ss.836-9, 2009 (SCI-Expanded)

18. sFRP1 promoter methylation is associated with persistent Philadelphia chromosome in chronic myeloid leukemia.

Pehlivan M., Sercan Z., Sercan H. O.

Leukemia research , cilt.33, sa.8, ss.1062-7, 2009 (SCI-Expanded)

19. Induction of apoptosis increases expression of non-canonical WNT genes in myeloid leukemia cell lines

Sercan H. O., Pehlivan M., Simsek Ö., Ateş H., Sercan Z.

ONCOLOGY REPORTS , cilt.18, sa.6, ss.1563-1569, 2007 (SCI-Expanded)

20. Analysis of cytotoxic T lymphocyte antigen-4 (CTLA-4) exon 1 polymorphism in patients with type 1 diabetes mellitus in a Turkish population

Genc Ş., Genc K., Sercan O., Kizildag S., Gulay Z., Atay T., et al.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM , cilt.17, sa.5, ss.731-735, 2004 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

21. MLL-AF4 gene rearrangement in a child with Epstein-Baff virus-related posttransplant B-cell lymphoma

Corapcioglu F., Olgun N., Sarialioglu F., Uysal K., Oren H., Sercan O.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , cilt.25, sa.9, ss.740-742, 2003 (SCI-Expanded, Scopus)

22. MLL-AF4 gene rearrangement in a child with Epstein-Barr virus-related posttransplant B-cell lymphoma

Çorapçioǧlu F., Olgun N., Sarialioǧlu F., Mutafoǧlu Uysal K., ÖREN H., SERCAN H. O.

Journal of Pediatric Hematology/Oncology , cilt.25, sa.9, ss.740-742, 2003 (SCI-Expanded)

23. Microsatellite instability is not a common feature in medullary breast cancer

Yuksel E., Ozer E., Kizildag S., Sercan O., Canda T., Sakizli M.

BREAST , cilt.11, sa.6, ss.473-477, 2002 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

24. Microsatellite instability in early-onset breast cancer

Ozer E., Yuksel E., Kizildag S., Sercan O., Ozen E., Canda T., et al.

PATHOLOGY RESEARCH AND PRACTICE , cilt.198, sa.8, ss.525-530, 2002 (SCI-Expanded, Scopus)

25. Microsatellite instability is a rare phenomenon in transition from chronic to blastic phase chronic myeloid leukemia

SERCAN H. O., Sercan Z., KIZILDAĞ S., Sakizli M.

Turkish Journal of Cancer , cilt.31, sa.2, ss.63-71, 2001 (Scopus)

26. Consistent loss of heterozygosity at 14q32 in lymphoid blast crisis of chronic myeloid leukemia

Sercan H. O., Sercan Z., Kizildag S., Undar B., Soydan S., Sakizli M.

LEUKEMIA & LYMPHOMA , cilt.39, sa.3-4, ss.385-390, 2000 (SCI-Expanded)

27. Mitochondrial cytochrome oxidase activity in renal cell carcinoma

Kirkali G., Gezer S., Sercan Z. Y., Akhunlar H., Sercan O., Kirkali Z.

Turkish Journal of Cancer , cilt.30, sa.1, ss.24-30, 2000 (Scopus, TRDizin)

28. Molecular detection of bcr/abl m-RNA and cytogenetic analysis in CML patients: Comparison of results and factors affecting the methodologies used

SERCAN H. O., Eresen C., Yuksei E., Sercan Z., PARALI F., ALTUNGÖZ O., et al.

Turkish Journal of Cancer , cilt.28, sa.4, ss.166-173, 1998 (Scopus)

29. A Turkish family with 6.7 kb deletion associated with isolated growth hormone deficiency type 1A

KORKMAZ K. S., Sercan O., Yazicioglu M., Sakizli M., Darcan S., Buyukgebiz A.

TURKISH JOURNAL OF PEDIATRICS , cilt.39, sa.1, ss.99-104, 1997 (SCI-Expanded)

30. Two brothers with a 7.0 kb gene deletion associated with isolated growth hormone deficiency type 1A

Sercan O., KORKMAZ K. S., Yazicioglu M., Sakizli M., Buyukgebiz A.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM , cilt.9, sa.3, ss.423-427, 1996 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 9

1. KML ve KML Kanser Kök Hücrelerindeki MikroRNA ekspresyon profillerinin karşılaştırılması

PEHLİVAN M., SOYÖZ M., Karahan H. İ., ÇERÇİ GÜRBÜZ B., KILIÇASLAN AYNA T., ATEŞ H., et al.

Uluslararası Hipokrat Tıp ve Sağlık Bilimleri Kongresi, Ankara, Türkiye, 1 - 03 Mart 2019, ss.64-65, (Özet Bildiri) Sürdürülebilir Kalkınma

2. The expression and a possible oncogenic effect of Dvl in CML

çalışkan c., SERCAN H. O.

EMBO conference: Wnt Meeting 2016, 14 - 17 Eylül 2016, (Özet Bildiri)

3. The role of sFRP1 in CML Progression

PEHLİVAN M., çalışkan c., YÜCE Z., SERCAN H. O.

Wnt Meeting 2016, 14 - 17 Eylül 2016, (Tam Metin Bildiri)

4. Determining the oncogenic effect of Dvl in CML

Caliskan C., Sercan O.

41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Türkiye, 3 - 08 Eylül 2016, cilt.283, ss.138-139, (Özet Bildiri)

5. Bilimsel Araştırma Projesi Hazırlamada dikkat edilecek noktalar

SERCAN H. O.

7.Ulusal Haseki Tıp Kongresi, Gazimagusa, Kıbrıs (Kktc), 5 - 08 Mayıs 2016

6. Kronik Miyeloid Lösemide Wif1 Proteininin Tedavi Direncinin Aşılmasına Etkisi

PEHLİVAN M., Ceyda Ç., ATEŞ H., Feriha Ö., YÜCE Z., SERCAN H. O.

II Uluslararası Katılımlı Deneysel Hematoloji Kongresi, Türkiye, 16 - 19 Nisan 2015, (Özet Bildiri) Sürdürülebilir Kalkınma

7. Low frequency of favorable genotypes in pediatric precursor B-cell acute lymphoblastic leukemia patients in western Turkey

Sercan H. O., Yuksel E., Kizildag S., CİNGÖZ S., Vergin C., Oren H., et al.

6th European Cytogenetics Conference, İstanbul, Türkiye, 7 - 10 Temmuz 2007, cilt.15, ss.203, (Özet Bildiri)

8. 1992-1995 yılları arasında, DEÜTF Tıbbi Biyoloji Laboratuarına KML ön tanısı ile gönderilen hastaların sitogenetik analiz sonuçları

YÜKSEL E., YÜCE Z., ALTUNGÖZ O., PARALI F., AY M. E., ÇAKMAKOĞLU Ş., et al.

XII. Uusal Kanser Kongresi, Antalya, Türkiye, 23 - 26 Nisan 1997, ss.254, (Özet Bildiri)

9. Akut lenfoblastik lösemi (ALL) ve rronik myeloid lösemi (KML) ön tanısı ile gönderilen hastaların sitogenetik analiz sonuçları

YÜKSEL E., YÜCE Z., ALTUNGÖZ O., PARALI F., AY M. E., ÇAKMAKOĞLU Ş., et al.

XII.Ulusal Kanser Kongresi, Antalya, Türkiye, 23 - 26 Nisan 1997, ss.254, (Özet Bildiri)

Yayınlar & Eserler